High Financial Burden Up With ASCVD in Low-Income Families

Share this content:
High Financial Burden Up With ASCVD in Low-Income Families
High Financial Burden Up With ASCVD in Low-Income Families

TUESDAY, July 10, 2018 (HealthDay News) -- Low-income families that include a member with atherosclerotic cardiovascular disease (ASCVD) have increased odds of high financial burden and catastrophic financial burden, according to a study published online July 3 in JAMA Cardiology.

Rohan Khera, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues conducted a cross-sectional study of the Medical Expenditure Panel Survey from January 2006 through December 2015 to examine the annual burden of total out-of-pocket health expenses among low-income families that included a member with ASCVD. A total of 22,521 adults with ASCVD, represented in 20,600 families, were identified.

The researchers found that the mean annual family income was $57,143, with mean out-of-pocket expenses of $4,415. Throughout the study there was a decrease in financial burden from health expenses; however, even in 2014 and 2015, low- versus mid/high-income families had increased odds of high financial burden (21.4 versus 7.6 percent; odds ratio, 3.31) and catastrophic financial burden (9.8 versus 1.2 percent; odds ratio, 9.35). In 2014 and 2015, even among the insured, 1.6 million low-income families nationally (21.8 percent) experienced high financial burden and 721,000 low-income families (9.8 percent) experienced catastrophic out-of-pocket health care expenses.

"To alleviate economic disparities, policy interventions must extend focus to improving not only access, but also quality of coverage, particularly for low-income families," the authors write.

One author disclosed financial ties to the pharmaceutical and medical device industries.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »